FDA approves Jardiance (empagliflozin) for the treatment of type 2 diabetes in children 10 years and older Read more
FDA GRANTS FULL APPROVAL FOR BLINCYTO (BLINATUMOMAB) TO TREAT MINIMAL RESIDUAL DISEASE-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA Read more
Ultragenyx Opens New Gene Therapy Manufacturing Facility in Bedford, Continuing its Expansion in Massachusetts Read more
Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Read more
FDA Approved Utidelone Injectable (UTD1) Phase 2/3 Multi-National Clinical Trial for Non-Small Cell Lung Cancer Read more
Sandoz introduces Act4Biosimilars Action Plan to accelerate patient access to biosimilar medicines Read more
Soliris approved in China for the treatment of adults with refractory generalised myasthenia gravis Read more